Clinical TopicsUncategorizedWeb Exclusives
fda cognitive behavioral therapy

FDA approves mobile app to encourage retention in opioid use disorder recovery programs


On Dec. 10, the FDA approved reSET-O app, a prescription cognitive behavioral therapy designed to encourage those with opioid use disorder to stay in recovery programs.

Read more via U.S. Food & Drug Administration.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.


Recent Posts